Acute Stroke Management Guidelines

Evidence Against Citicoline Use

The American Heart Association/American Stroke Association guidelines state that citicoline cannot be recommended for acute ischemic stroke treatment due to lack of consistent efficacy (Grade A recommendation) 1
The International Citicoline Trial on Acute Stroke found no difference in 90-day global outcome between citicoline and placebo in 2,298 patients with moderate to severe ischemic stroke 1

The American Heart Association recommends immediate brain imaging with non-contrast CT or MRI to determine stroke type and eligibility for evidence-based treatments 2, 3
The American College of Chest Physicians recommends IV recombinant tissue plasminogen activator (r-tPA) for patients with confirmed ischemic stroke within 3 hours (Grade 1A) or 4.5 hours (Grade 2C) of symptom onset 4, 5
Early aspirin therapy (160-325 mg) is recommended within 48 hours for patients with acute ischemic stroke who are not receiving thrombolysis 4, 5
Endovascular thrombectomy should be considered for patients with large vessel occlusions within appropriate time windows 2, 3

Rapid neurological assessment using a standardized stroke scale such as the National Institutes of Health Stroke Scale (NIHSS) is recommended 2, 3
Initial blood work including electrolytes, random glucose, and coagulation status should be conducted without delaying imaging or treatment decisions 2
Assessment of vital signs including heart rate, blood pressure, and oxygen saturation is crucial 2

Time is critical in acute stroke management, and focus should be on rapid assessment, imaging, and administration of proven therapies rather than unproven neuroprotective agents 2, 3
The management of physiological parameters, including blood pressure control, is crucial in acute ischemic stroke care 3
Patients with suspected stroke should be treated in specialized stroke units with coordinated care by interdisciplinary teams with expertise in stroke management 3

The American Heart Association/American Stroke Association recommends early aspirin therapy (160-325 mg) within 24-48 hours for patients not receiving thrombolysis, after intracranial hemorrhage is excluded, as stated by the International Journal of Stroke 6, 7
Blood pressure should be lowered to <185/110 mmHg before thrombolysis or thrombectomy and maintained <180/105 mmHg for 24 hours afterward, according to the European Heart Journal and Stroke 8, 9, 10

For patients not receiving reperfusion therapy, blood pressure should only be lowered if extremely elevated (>220/120 mmHg), with a modest 10-15% reduction over hours, as recommended by the European Heart Journal 8